Filing Details
- Accession Number:
- 0001387131-17-001594
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-23 17:31:04
- Reporting Period:
- 2017-03-21
- Filing Date:
- 2017-03-23
- Accepted Time:
- 2017-03-23 17:31:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528557 | Corindus Vascular Robotics Inc. | CVRS | Surgical & Medical Instruments & Apparatus (3841) | 300687898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1700257 | A Louis Cannon | 309 Waverley Oaks Road, Suite 105 Waltham MA 02452 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-21 | 26,027 | $1.30 | 26,027 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-22 | 973 | $1.32 | 27,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.32, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Shares held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon.
- These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.32, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.